Key facts
- Parallel (Clinics/Outpatient Services)’s last known valuation is $117.0M (Dec 2025).
- It has raised $49.1M; the latest was Later Stage VC ($20.0M) in Dec 2025.
- Notable investors include Tiger Global Management, Global Founders Capital, Pareto Holdings, Great Oaks Venture Capital, Browder Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Parallel (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Parallel (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Parallel (Clinics/Outpatient Services)
Developer of digital mental health assessment platform designed for educational and therapeutic purposes. The company's platform provides virtual therapy sessions, personalized treatment plans, progress tracking tools, and secure communication features, enabling schools and students to access licensed clinicians remotely, improve mental health support, and integrate care seamlessly into academic environments.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 160
- Website
- parallellearning.com/
- Ownership
- Privately Held (backing)
Parallel (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Parallel (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Parallel (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.